glp 1 agonists adverse effects The promise and peril of GLP-1 agonists: What we do (and don't) know as of August 2024 Clinical Focus on GLP-1 Agonists
Description
Combination therapy with insulin glargine and exenatide: real-world outcomes in patients with type 2 diabetes
And how quickly should treatment be initiated, and does this depend on any specific circumstances
The antidepressant effects of GLP-1 receptor agonists: A systematic review and Meta-Analysis
GLP-1R agonist treatment also leads to a mild decrease in cholesterol levels (total, LDL, and triglyceride), an additional factor that participates in the pathogenesis and progression of such kidney disease [76]
